Common use of Minimum Revenue Clause in Contracts

Minimum Revenue. As of the last day of each fiscal quarter set forth below, the Borrower and its Subsidiaries shall have received Revenue (exclusive of any non-recurring Revenue from royalties, licenses or other sources), for the twelve (12) consecutive month period ending on the last day of such fiscal quarter, in an aggregate amount not less than the corresponding amount set forth opposite such fiscal quarter: Fiscal Quarter Ending Revenue June 30, 2019 $34,322,000 September 30, 2019 $35,945,000 December 31, 2019 $36,710,000 March 31, 2020 $38,162,000 June 30, 2020 $43,193,000 September 30, 2020 $48,225,000 December 31, 2020 $54,262,000 March 31, 2021 $58,550,000 June 30, 2021 $63,909,000 September 30, 2021 $69,269,000 December 31, 2021 $75,700,000 March 31, 2022 $80,618,000 June 30, 2022 $86,765,000 September 30, 2022 $92,913,000 December 31, 2022 $100,289,000 March 31, 2023 $102,628,000

Appears in 2 contracts

Samples: Credit Agreement and Guaranty (ArcherDX, Inc.), Credit Agreement and Guaranty (ArcherDX, Inc.)

AutoNDA by SimpleDocs

Minimum Revenue. As of the last day of each fiscal quarter set forth belowbelow (each, the Borrower a “Calculation Date”), Holdings and its Subsidiaries shall have received Revenue (exclusive of any non-recurring Revenue from royalties, licenses or other sources)Revenue, for the trailing twelve (12) month consecutive month period ending on the last day of such fiscal quarterCalculation Date, in an aggregate amount not less than the corresponding amount set forth opposite such fiscal quarterCalculation Date: Fiscal Quarter Ending Calculation Date Revenue June 30, 2019 $34,322,000 September 30, 2019 $35,945,000 December 31, 2019 $36,710,000 March 31, 2020 $38,162,000 June 30, 2020 $43,193,000 September 30, 2020 $48,225,000 December 31, 2020 $54,262,000 March 31, 2021 $58,550,000 June 30, 2021 $63,909,000 September 30, 2021 $69,269,000 December 31, 2021 $75,700,000 March 31, 2022 $80,618,000 5,750,000 June 30, 2022 $86,765,000 7,750,000 September 30, 2022 $92,913,000 11,000,000 December 31, 2022 $100,289,000 18,000,000 March 31, 2023 $102,628,00026,000,000 79 Calculation Date Revenue June 30, 2023 $44,000,000 September 30, 2023 $69,000,000 December 31, 2023 $100,000,000 March 31, 2024 $125,000,000 June 30, 2024 $125,000,000 September 30, 2024 $125,000,000 December 31, 2024 $125,000,000 March 31, 2025 $125,000,000

Appears in 2 contracts

Samples: Credit Agreement (Pear Therapeutics, Inc.), Credit Agreement (Pear Therapeutics, Inc.)

Minimum Revenue. As of the last day of each fiscal quarter set forth below, the Borrower and its Subsidiaries Obligors shall have received Revenue (exclusive in the ordinary course of any non-recurring Revenue from royalties, licenses or other sources)business, for the twelve (12) month consecutive month period ending on the last day of such fiscal quarter, in an aggregate amount not less than the corresponding amount set forth opposite such fiscal quarter: ny-2328495 Fiscal Quarter Ending Revenue June 30, 2019 $34,322,000 September 30, 2019 $35,945,000 December 31, 2019 $36,710,000 March 31, 2020 $38,162,000 June 30, 2020 $43,193,000 September 30, 2020 $48,225,000 December 31, 2020 $54,262,000 March 31, 2021 $58,550,000 June 30, 2021 $63,909,000 September 30, 2021 $69,269,000 December 31, 2021 $75,700,000 March 31, 2022 $80,618,000 June 30, 2022 $86,765,000 September 30, 2022 $92,913,000 December 31, 2022 $100,289,000 80,000,000 March 31, 2023 $102,628,00085,000,000 June 30, 2023 $90,000,000 September 30, 2023 $95,000,000 December 31, 2023 $100,000,000 March 31, 2024 $110,000,000 June 30, 2024 $125,000,000 September 30, 2024 $150,000,000 December 31, 2024 $150,000,000 March 31, 2025 $150,000,000 June 30, 2025 $150,000,000 September 30, 2025 $150,000,000 December 31, 2025 $150,000,000 March 31, 2026 $150,000,000 June 30, 2026 $150,000,000 September 30, 2026 $150,000,000 December 31, 2026 $150,000,000 March 31, 2027 and each fiscal quarter thereafter $150,000,000

Appears in 1 contract

Samples: Credit Agreement and Guaranty (Xeris Biopharma Holdings, Inc.)

Minimum Revenue. As of On each calculation date set forth below in the last day of each column entitled “Calculation Date” (each, a “Calculation Date”), Revenue for the four consecutive fiscal quarter set forth below, the Borrower and its Subsidiaries period ended on such Calculation Date shall have received Revenue (exclusive of any non-recurring Revenue from royalties, licenses or other sources), for the twelve (12) consecutive month period ending on the last day of such fiscal quarter, in an aggregate amount not be less than the corresponding amount set forth opposite such fiscal quarterin the column entitled “Revenue”: Fiscal Quarter Ending Calculation Date Revenue June 30, 2018 $ 35,792,000 September 30, 2018 $ 36,787,000 December 31, 2018 $ 38,779,000 March 31, 2019 $34,322,000 $ 41,316,000 June 30, 2019 $ 43,019,000 September 30, 2019 $35,945,000 $ 44,612,000 December 31, 2019 $36,710,000 $ 46,114,000 March 31, 2020 $38,162,000 $ 47,242,000 June 30, 2020 $43,193,000 $ 48,321,000 September 30, 2020 $48,225,000 December 31, 2020 $54,262,000 March 31, 2021 $58,550,000 June 30, 2021 $63,909,000 September 30, 2021 $69,269,000 December 31, 2021 $75,700,000 March 31, 2022 $80,618,000 June 30, 2022 $86,765,000 September 30, 2022 $92,913,000 December 31, 2022 $100,289,000 March 31, 2023 $102,628,000$ 49,376,000

Appears in 1 contract

Samples: Business Financing Agreement (Vapotherm Inc)

Minimum Revenue. As of the last day of each fiscal quarter set forth below, the Borrower and its Subsidiaries shall have received Revenue (exclusive of any non-recurring Revenue from royalties, licenses or other sources), for the twelve (12) consecutive month period ending on the last day of such fiscal quarter, in an aggregate amount not less than the corresponding amount set forth opposite such fiscal quarter: Fiscal Quarter Ending Revenue June 30, 2019 $34,322,000 7,041,000 September 30, 2019 $35,945,000 6,244,000 December 31, 2019 $36,710,000 7,780,000 March 31, 2020 $38,162,000 11,004,000 June 30, 2020 $43,193,000 14,761,000 September 30, 2020 $48,225,000 19,626,000 December 31, 2020 $54,262,000 23,588,000 March 31, 2021 $58,550,000 31,193,000 June 30, 2021 $63,909,000 37,341,000 September 30, 2021 $69,269,000 45,420,000 December 31, 2021 $75,700,000 March 31, 2022 $80,618,000 June 30, 2022 $86,765,000 September 30, 2022 $92,913,000 December 31, 2022 $100,289,000 March 31, 2023 $102,628,00054,974,000

Appears in 1 contract

Samples: Credit Agreement and Guaranty (Adma Biologics, Inc.)

AutoNDA by SimpleDocs

Minimum Revenue. As of the last day of each fiscal quarter set forth belowbelow (each, a “Calculation Date”), the Borrower and its Subsidiaries shall have received Revenue (exclusive of any non-recurring Revenue from royalties, licenses or other sources)Revenue, for the trailing twelve (12) month consecutive month period ending on the last day of such fiscal quarterCalculation Date, in an aggregate amount not less than the corresponding amount set forth opposite such fiscal quarterCalculation Date: Fiscal Quarter Ending Calculation Date Revenue June 30, 2019 $34,322,000 September 30, 2019 $35,945,000 December 31, 2019 $36,710,000 March 31, 2020 $38,162,000 June 30, 2020 $43,193,000 September 30, 2020 $48,225,000 December 31, 2020 $54,262,000 March 31, 2021 $58,550,000 June 30, 2021 $63,909,000 13,971,000 September 30, 2021 $69,269,000 20,018,000 December 31, 2021 $75,700,000 26,364,000 March 31, 2022 $80,618,000 43,949,000 June 30, 2022 $86,765,000 59,158,000 September 30, 2022 $92,913,000 73,428,000 December 31, 2022 $100,289,000 83,409,000 March 31, 2023 $102,628,000101,606,000 June 30, 2023 $119,803,000 September 30, 2023 $125,000,000 December 31, 2023 $125,000,000 March 31, 2024 $125,000,000 June 30, 2024 $125,000,000 September 30, 2024 $125,000,000 December 31, 2024 $125,000,000 March 31, 2025 $125,000,000

Appears in 1 contract

Samples: Credit Agreement (Thimble Point Acquisition Corp.)

Minimum Revenue. As of the last day of each fiscal quarter set forth below, the Borrower Parent and its Subsidiaries shall have received consolidated Revenue (exclusive of any non-recurring Revenue from royalties, licenses or other sources), for the period of twelve (12) consecutive month period months ending on the last day of such fiscal quarter, determined on the basis of the financial statements most recently delivered pursuant to Sections 8.01(b) or 8.01(c), as applicable, in an aggregate amount not less than the corresponding amount set forth opposite such fiscal quarter: Fiscal Quarter Ending TTM Revenue September 30, 2023 $ 63.6 million December 31, 2023 $ 80.5 million March 31, 2024 $ 92.0 million June 30, 2019 $34,322,000 2024 $ 105.5 million September 30, 2019 $35,945,000 2024 $ 98.3 million December 31, 2019 $36,710,000 2024 $ 108.0 million March 31, 2020 $38,162,000 2025 $ 119.6 million June 30, 2020 $43,193,000 2025 $ 125.8 million September 30, 2020 $48,225,000 December 31, 2020 $54,262,000 March 31, 2021 $58,550,000 June 30, 2021 $63,909,000 September 30, 2021 $69,269,000 December 31, 2021 $75,700,000 March 31, 2022 $80,618,000 June 30, 2022 $86,765,000 September 30, 2022 $92,913,000 December 31, 2022 $100,289,000 March 31, 2023 $102,628,0002025 and Thereafter $ 107.3 million SECTION 11

Appears in 1 contract

Samples: Credit Agreement and Guaranty (Allurion Technologies, Inc.)

Minimum Revenue. As of the last day of each fiscal quarter Fiscal Quarter set forth below, the Borrower and its Subsidiaries shall have received Revenue (exclusive of any non-recurring Revenue from royalties, licenses or other sources), for the twelve (12) consecutive month period ending on the last day of such fiscal quarterFiscal Quarter, in an aggregate amount not less than the corresponding amount set forth opposite such fiscal quarterFiscal Quarter: Fiscal Quarter Ending Revenue December 31, 2018 $60,000,000 March 31, 2019 $60,000,000 June 30, 2019 $34,322,000 60,000,000 September 30, 2019 $35,945,000 60,000,000 December 31, 2019 $36,710,000 60,000,000 March 31, 2020 $38,162,000 60,000,000 June 30, 2020 $43,193,000 60,000,000 September 30, 2020 $48,225,000 66,000,000 67 December 31, 2020 $54,262,000 $ 66,000,000 March 31, 2021 $58,550,000 $ 66,000,000 June 30, 2021 $63,909,000 $ 66,000,000 September 30, 2021 $69,269,000 $ 72,600,000 December 31, 2021 $75,700,000 $ 72,600,000 March 31, 2022 $80,618,000 $ 72,600,000 June 30, 2022 $86,765,000 $ 72,600,000 September 30, 2022 $92,913,000 $ 79,860,000 December 31, 2022 $100,289,000 $ 79,860,000 March 31, 2023 $102,628,000$ 79,860,000 June 30, 2023 $ 79,860,000 SECTION 11.

Appears in 1 contract

Samples: Credit Agreement and Guaranty (Athenex, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.